The global Antibiotics Market size is expected to reach USD
62.06 billion by 2025 expanding at a CAGR of 4.0%, according to a new report by
Grand View Research, Inc. Rising prevalence of infectious diseases, especially
in developing regions like Asia Pacific and Middle East, is anticipated to
contribute to the market growth. More than 15.0% of the deaths in children
below the age of five years, are estimated to be due to pneumonia and according
to the statistics provided by the WHO about 9.2 million deaths were recorded in
2015. Similar to tuberculosis, the disease is highly prevalent in the South
Asian and Sub-Saharan regions. Currently, the required antibiotic treatment is
available only to one-third of the infected population, thereby increasing the
disease burden.
Government reforms specific to
antibiotics, such as the Generating Antibiotics Incentives Now (GAIN) Act in
U.S., are projected to help boost the market growth over the forecast period.
This is further expected to facilitate development of advanced drugs. According
to an article published by the Pew Charitable Trusts, nearly 30% of the
outpatient oral antibiotics prescriptions are unnecessary and majority of these
are prescribed for disease conditions, such as non-bacterial infections and
acute respiratory conditions, against which antibiotics are not significantly
effective. Such indiscriminate use of antibiotics is anticipated to increase
the risk of difficult-to-treat antibiotic-resistant infections, thereby
increasing the economic burden.
Browse Details Of Report @ https://www.grandviewresearch.com/industry-analysis/antibiotic-market
Further key findings from the study suggest:
- RNA and folic acid synthesis inhibitors are
anticipated to witness healthy CAGRs over the forecast period
- Development of several antiviral drugs, which
inhibit transcription and reverse transcription process are anticipated to
support this growth
- Asia Pacific is anticipated to witness the
highest CAGR over the forecast period on account of large population base,
prevalence of infectious diseases, regulation reforms, and wide usage of generic
medicine
- Latin America, especially Brazil, is also
projected to exhibit remunerative growth due to strong growth in
pharmaceutical sector
- Outbreak of certain viruses, such as Ebola, in
African region contributed to the region’s growth
- Some of the key companies in the market are
Pfizer, Inc; Janssen Pharmaceuticals; Abbott laboratories; GlaxoSmithKline
plc; Sanofi S.A.; Novartis AG; Bayer AG; Bristol Myers Squibb Company; Eli
Lilly & Company, and Astellas Pharma, Inc.
Grand View Research has
segmented the global antibiotics market on the basis of action mechanism, drug
class, and region:
Antibiotics Action Mechanism Outlook (Revenue, USD
Million, 2015 - 2026)
- Cell Wall Synthesis Inhibitors
- Protein Synthesis Inhibitors
- DNA Synthesis Inhibitors
- RNA Synthesis Inhibitors
- Mycolic Acid Inhibitors
Antibiotics Drug Class Outlook (Revenue, USD Million,
2015 - 2026)
- Cephalosporin
- Penicillin
- Fluoroquinolone
- Macrolides
- Carbapenems
- Aminoglycosides
- Sulfonamide
- Other
Antibiotics Regional Outlook (Revenue, USD Million, 2015
- 2026)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Asia Pacific
- China
- Japan
- India
- Thailand
- South Korea
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- MEA
- South Africa
- Saudi Arabia
- UAE
About
Grand View Research, Inc.:
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc
Phone: 1-415- 349-0058
Toll Free: 1-888- 202-9519
Email: sales@grandviewresearch.com
For More Information: http://www.grandviewresearch.com
No comments:
Post a Comment